pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer
Theranostics · 2025
DOI: 10.7150/thno.107200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Ning Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Programmed Cell Death 1 Receptor, Cancer Vaccines, Immunotherapy. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Zitieren
APA
Wang, N., Yu, H., Yin, J., & Yu, X. (2025). pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer. Theranostics. https://doi.org/10.7150/thno.107200
Vancouver
Wang N, Yu H, Yin J, Yu X. pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer. Theranostics. 2025. doi:10.7150/thno.107200
BibTeX
@article{Wang2025,
author = {Wang, Ning and Yu, Hong and Yin, Jianqiao and Yu, Xiaopeng},
title = {pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.107200}
}
EUVIMED